199 related articles for article (PubMed ID: 10971456)
1. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
[TBL] [Abstract][Full Text] [Related]
2. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Eur J Endocrinol; 2003 Apr; 148(4):403-11. PubMed ID: 12656660
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
[TBL] [Abstract][Full Text] [Related]
6. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
[TBL] [Abstract][Full Text] [Related]
7. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
[TBL] [Abstract][Full Text] [Related]
8. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
9. [The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease].
Ilyicheva EA; Shurygina IA; Dremina NN; Bersenev GA; Grigoryev EG
Probl Endokrinol (Mosk); 2023 Jun; 69(3):24-34. PubMed ID: 37448244
[TBL] [Abstract][Full Text] [Related]
10. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism.
Grzela T; Chudzinski W; Lasiecka Z; Niderla J; Wilczynski G; Gornicka B; Wasiutynski A; Durlik M; Boszczyk A; Brawura-Biskupski-Samaha R; Dziunycz P; Milewski L; Lazarczyk M; Lazarczyk M; Nawrot I
Int J Mol Med; 2006 May; 17(5):779-83. PubMed ID: 16596260
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
[TBL] [Abstract][Full Text] [Related]
12. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical detection of a reduction in 1,25 dihyroxyvitamin D3 receptor expression in uraemic parathyroid tissue.
Fletcher S; Brownjohn AM; Dunwell C; Harnden P
Nephrol Dial Transplant; 1997 Jan; 12(1):93-6. PubMed ID: 9027780
[TBL] [Abstract][Full Text] [Related]
14. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
15. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
18. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.
Uchiyama T; Tatsumi N; Kamejima S; Waku T; Ohkido I; Yokoyama K; Yokoo T; Okabe M
Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas.
Chikatsu N; Fukumoto S; Takeuchi Y; Suzawa M; Obara T; Matsumoto T; Fujita T
J Biol Chem; 2000 Mar; 275(11):7553-7. PubMed ID: 10713061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
